Exclude Patient Type Detail Header
No
Footnote
<sup>1</sup> <b>NIH 2023.</b> COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Last update 11/2/23. <a href=https://www.covid19treatmentguidelines.nih.gov/><u>Accessed 11/13/23</u></a>
<br><br>
<sup>2</sup> <b>IDSA 2023.</b> Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19. Last update 6/26/23. <a href=https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/><u>Accessed 11/13/23</u></a>
<br><br>
<sup>3</sup> <b>WHO 2023.</b> Therapeutics and COVID-19: Living Guideline. World Health Organization. Last update 1/13/23. <a href=https://www.who.int/publications/i/item/WHO-2019-nCoV-therapeutics-2023.1><u>Accessed 3/15/23</u></a>
<br><br>
Pts at high risk of hospitalization include those w/ diagnosed immunodeficiency syndromes, solid organ transplant recipients being treated w/ immunosuppressants, and those w/ autoimmune illness receiving immunosuppressants.
<br><br>
Pts at moderate risk of hospitalization are those >65 yo, those w/ obesity, diabetes, or a chronic condition such as COPD, kidney or liver dz, or cancer, those w/ disabilities, and those w/ comorbidities of chronic dz.
<br><br>
<sup>4</sup> <b>NIH 2023.</b> Consider longer or additional courses in immunocompromised pts w/ prolonged symptomatic COVID-19 and evidence of ongoing viral replication despite antiviral tx.
<br><br>
<sup>2</sup> <b>IDSA 2023.</b> Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19. Last update 6/26/23. <a href=https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/><u>Accessed 11/13/23</u></a>
<br><br>
<sup>3</sup> <b>WHO 2023.</b> Therapeutics and COVID-19: Living Guideline. World Health Organization. Last update 1/13/23. <a href=https://www.who.int/publications/i/item/WHO-2019-nCoV-therapeutics-2023.1><u>Accessed 3/15/23</u></a>
<br><br>
Pts at high risk of hospitalization include those w/ diagnosed immunodeficiency syndromes, solid organ transplant recipients being treated w/ immunosuppressants, and those w/ autoimmune illness receiving immunosuppressants.
<br><br>
Pts at moderate risk of hospitalization are those >65 yo, those w/ obesity, diabetes, or a chronic condition such as COPD, kidney or liver dz, or cancer, those w/ disabilities, and those w/ comorbidities of chronic dz.
<br><br>
<sup>4</sup> <b>NIH 2023.</b> Consider longer or additional courses in immunocompromised pts w/ prolonged symptomatic COVID-19 and evidence of ongoing viral replication despite antiviral tx.
Detail Type
Text
Detail Text
Patient Type Detail Header (Long)
General mgmt